Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104956 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Eva M Struijf und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Complement C5, Single-Domain Antibodies. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Horizon 2020, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
The human complement system plays a crucial role in immune defense. However, its erroneous activation contributes to many serious inflammatory diseases. Since most unwanted complement effector functions result from C5 cleavage into C5a and C5b, development of C5 inhibitors, such as clinically approved monoclonal antibody eculizumab, are of great interest. Here, we developed and characterized two anti-C5 nanobodies, UNbC5-1 and UNbC5-2. Using surface plasmon resonance, we determined a binding affinity of 119.9 pM for UNbC5-1 and 7.7 pM for UNbC5-2. Competition experiments determined that the two nanobodies recognize distinct epitopes on C5. Both nanobodies efficiently interfered with C5 cleavage in a human serum environment, as they prevented red blood cell lysis via membrane attack complexes (C5b-9) and the formation of chemoattractant C5a. The cryo-EM structure of UNbC5-1 and UNbC5-2 in complex with C5 (3.6 Å resolution) revealed that the binding interfaces of UNbC5-1 and UNbC5-2 overlap with known complement inhibitors eculizumab and RaCI3, respectively. UNbC5-1 binds to the MG7 domain of C5, facilitated by a hydrophobic core and polar interactions, and UNbC5-2 interacts with the C5d domain mostly by salt bridges and hydrogen bonds. Interestingly, UNbC5-1 potently binds and inhibits C5 R885H, a genetic variant of C5 that is not recognized by eculizumab. Altogether, we identified and characterized two different, high affinity nanobodies against human C5. Both nanobodies could serve as diagnostic and/or research tools to detect C5 or inhibit C5 cleavage. Furthermore, the residues targeted by UNbC5-1 hold important information for therapeutic inhibition of different polymorphic variants of C5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Structural Biochemistry Group, Faculty of Science, Department of Chemistry, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
- QVQ Holding BV, Utrecht, The Netherlands.
- Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address: s.h.m.rooijakkers@umcutrecht.nl.
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Horizon 2020
- Horizon 2020 Framework Programme
- ERC
- Consejo Nacional de Ciencia y Tecnología
- European Research Council
Zitieren
APA
Struijf, E. M., De la O Becerra, K. I., Ruyken, M., de Haas, C. J. C., van Oosterom, F., Siere, D. Y., van Keulen, J. E., Heesterbeek, D. A. C., Dolk, E., Heukers, R., Bardoel, B. W., Gros, P., & Rooijakkers, S. H. M. (2023). Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104956
Vancouver
Struijf EM, De la O Becerra KI, Ruyken M, de Haas CJC, van Oosterom F, Siere DY, et al. Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104956
BibTeX
@article{Struijf2023,
author = {Struijf, Eva M and De la O Becerra, Karla I and Ruyken, Maartje and de Haas, Carla J C and van Oosterom, Fleur and Siere, Danique Y and van Keulen, Joanne E and Heesterbeek, Dani A C and Dolk, Edward and Heukers, Raimond and Bardoel, Bart W and Gros, Piet and Rooijakkers, Suzan H M},
title = {Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104956}
}
EUVIMED